Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Mycobacterium leprae outer membrane** is a specialized lipid bilayer structure forming part of the unique cell envelope characteristic of mycobacteria. This "mycomembrane" consists primarily of very-long-chain fatty acids known as mycolic acids, which form its inner leaflet, while its outer leaflet contains various non-covalently linked lipids and glycolipids[2][3]. The presence and organization of this lipid-rich barrier are thought to contribute significantly to *M. leprae*'s natural resistance to many antibiotics and chemotherapeutic agents by restricting their entry into the bacterial cell[1][2]. Structurally, it is analogous in function—but not in composition—to the outer membranes found in Gram-negative bacteria. While some proteins are associated with transport across this barrier in related species (*e.g.*, MmpL family proteins), there is no evidence that the "outer membrane" itself constitutes a single therapeutic target such as an enzyme or receptor. Instead, it represents a complex structural feature essential for bacterial survival and pathogenicity but not typically targeted directly by drugs[1][2]. Notably, there are no standard abbreviations or alternative names specific only to *M. leprae*'s version; terms like "mycomembrane" or "outer mycolate layer" apply broadly across pathogenic mycobacteria including *M. tuberculosis*[3]. There is also some uncertainty about whether all detailed features described for other species fully apply to *M. leprae*, given differences observed at ultrastructural levels[3][4]. Because this term refers to an entire structural component rather than a discrete protein or receptor molecule—and because it does not represent a direct therapeutic target—the entry should be flagged as potentially incorrect if used where individual molecular targets are required. > The recent advent of cryoelectron microscopy has confirmed that the ‘lipid barrier’, or ‘outer mycolate layer’, is indeed a bona fide mycobacterial outer membrane... Although this exciting development applies mainly to M. tuberculosis... we expect likewise for M. leprae.[3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium leprae outer membrane.